Literature DB >> 8931291

Construction and expression of single-chain Fv antibody against human bladder carcinoma.

L Z Yu1, S Xiao, H L Huang, Z Gu, F L Gu, Y L Guo.   

Abstract

We designed two sets of oligonucleotide primers to amplify the immunoglobulin heavy- and light-chain variable-region genes from genomic DNA by polymerase chain reaction (PCR). The genomic DNA was extracted from hybridoma BDI-1 cells, which secreted a monoclonal antibody (mAb) against human bladder carcinoma. The primers contained special restriction sites that allowed the variable-region genes to be easily cloned for sequencing and expression. The recombinants were sequenced by Sanger's method. It was proved that the full lengths of the VH and VK genes were 366 and 324 bp, respectively. Compared with other published sequences, the VH gene was a member of mouse heavy-chain VH subgroup II and originated from the rearrangement of VH, Dsp2.2 and JH4. The VK gene was VK subgroup IV and from VK and JK4. The VH and VK genes was inserted expression vector pWAI80. By inducement, the ScFv antibodies were expressed and secreted from Escherichia coli. Binding activities against the bladder carcinoma cells were detected. We suggest that ScFv antibody recognized the antigen specifically.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931291     DOI: 10.1007/bf00304776

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  14 in total

1.  Construction of single-chain Fv derivatives monoclonal antibodies and their production in Escherichia coli.

Authors:  S Johnson; R E Bird
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli.

Authors:  E S Ward; D Güssow; A D Griffiths; P T Jones; G Winter
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

Review 3.  Human monoclonal antibody production. Current status and future prospects.

Authors:  K James; G T Bell
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

4.  Single-chain antigen-binding proteins.

Authors:  R E Bird; K D Hardman; J W Jacobson; S Johnson; B M Kaufman; S M Lee; T Lee; S H Pope; G S Riordan; M Whitlow
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

Review 5.  The use of monoclonal antibodies for the diagnosis and therapy of bladder cancer.

Authors:  P J Russell; J Plomley; D Raghavan
Journal:  Br J Urol       Date:  1993-02

Review 6.  Humanized antibodies.

Authors:  G Winter; W J Harris
Journal:  Immunol Today       Date:  1993-06

7.  Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

Authors:  S L Morrison; M J Johnson; L A Herzenberg; V T Oi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Radioimmunoimaging diagnosis of human bladder carcinoma.

Authors:  L Z Yu; F L Gu; C L Zhang
Journal:  Scand J Urol Nephrol Suppl       Date:  1994

9.  Human immune response to multiple injections of murine monoclonal IgG.

Authors:  D L Shawler; R M Bartholomew; L M Smith; R O Dillman
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

10.  Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.

Authors:  L Chatenoud; M F Baudrihaye; N Chkoff; H Kreis; G Goldstein; J F Bach
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.